https://www.businesswire.com/news/home/20231121718083/en/OSE-Immunotherapeutics-Announces-a-Collaboration-Agreement-with-GenDx-for-the-Development-of-a-Companion-Diagnostic-for-Epitope-Based-Cancer-Vaccine-Candidate-Tedopi
OSE Immunotherapeutics Announces a Collaboration Agreement with GenDx for the Development of a...
OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the Company has entered into a collaboration with GenDx (a Eurobio Scientific...
collaboration agreement
https://www.gendx.com/
GenDx: Experts in Transplant Diagnostics - GenDx
Jun 16, 2026 - GenDx offers NGS-based HLA typing, chimerism monitoring, and KIR typing kits for transplant diagnostics. Trusted by labs worldwide, with best-in-class software...
experts ingendxtransplantdiagnostics